Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jörg Wissel & Songjin Ri. (2022) Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice. Expert Review of Neurotherapeutics 22:1, pages 27-42.
Read now
Read now
Colin Pinder, Bipin Bhakta & Krishna Kodavali. (2008) Intrathecal phenol: an old treatment revisited. Disability and Rehabilitation 30:5, pages 381-386.
Read now
Read now
Karen S. G. Chua, Keng-He Kong. (2001) Clinical and functional outcome after alcohol neurolysis of the tibial nerve for ankle?foot spasticity. Brain Injury 15:8, pages 733-739.
Read now
Read now
Articles from other publishers (37)
Sheng Li, Paul Winston & Manuel F. Mas. (2023) Spasticity Treatment Beyond Botulinum Toxins. Physical Medicine and Rehabilitation Clinics of North America.
Crossref
Crossref
Bei Zhang, Nathan Darji, Gerard E. Francisco & Sheng Li. (2021) The Time Course of Onset and Peak Effects of Phenol Neurolysis. American Journal of Physical Medicine & Rehabilitation 100:3, pages 266-270.
Crossref
Crossref
Gerard E. Francisco, Jörg Wissel, Thomas Platz & Sheng Li. 2021. Clinical Pathways in Stroke Rehabilitation. Clinical Pathways in Stroke Rehabilitation
149
173
.
Yasin Demir, Ayça Uran Şan, Serdar Kesikburun, Evren Yaşar & Bilge Yılmaz. (2018) The short-term effect of ultrasound and peripheral nerve stimulator-guided femoral nerve block with phenol on the outcomes of patients with traumatic spinal cord injury. Spinal Cord 56:9, pages 907-912.
Crossref
Crossref
Tetsutaro Yahata. (2018) The Use of Peripheral Nerve Neurolysis in the Management of Limb Spasticity四肢痙縮コントロールにおける神経破壊剤を用いた末梢神経ブロックの意義. The Japanese Journal of Rehabilitation Medicine 55:6, pages 458-463.
Crossref
Crossref
Taha Peya, Yumnam Ningthemba Singh, Naorem Bimol, Tamphaleima Khuraijam, Nandabir Singh & Akoijam Joy Singh. (2017) EFFECTIVENESS OF PHENOL BLOCK IN THE MANAGEMENT OF SPASTICITY IN HEMIPLEGIA- A NONRANDOMISED CONTROLLED TRIAL. Journal of Evolution of Medical and Dental Sciences 6:94, pages 6905-6908.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
688
692
.
Nicolas Bayle & Jean-Michel Gracies. 2014. Textbook of Neural Repair and Rehabilitation. Textbook of Neural Repair and Rehabilitation
312
329
.
. 2014. Textbook of Neural Repair and Rehabilitation. Textbook of Neural Repair and Rehabilitation
289
384
.
Kei UNAI, Kaoru HONAGA, Toshiyuki FUJIWARA, Michiyuki KAWAKAMI, Tetsuya TSUJI & Meigen LIU. (2014) Effects on Spasticity and Gait using a 5% Phenol Motor Point Block in Patients with Chronic Hemiparesis. The Japanese Journal of Rehabilitation Medicine 51:4-5, pages 271-276.
Crossref
Crossref
Adel Abdullah Alhusaini. 2014. Cerebral Palsy in Infancy. Cerebral Palsy in Infancy
87
106
.
Gerard E. FranciscoJohn R. McGuire. (2012) Poststroke Spasticity Management. Stroke 43:11, pages 3132-3136.
Crossref
Crossref
Alberto Esquenazi. 2012. Handbook of Dystonia. Handbook of Dystonia
476
488
.
. 2010. Meyler's Side Effects of Antimicrobial Drugs. Meyler's Side Effects of Antimicrobial Drugs
1085
1134
.
A. Magid O. Bakheit. 2009. Upper Motor Neurone Syndrome and Spasticity. Upper Motor Neurone Syndrome and Spasticity
150
164
.
Robert E. Molloy & Honorio T. Benzon. 2008. Raj's Practical Management of Pain. Raj's Practical Management of Pain
839
850
.
Socorro Romero-Figueroa, J. Antonio Aldrete, Angelina Mart?nez-Cruz, Sandra Orozco, Sebastian Castillo, Carlos Castillo-Henkel & Gabriel Gu?zar-Sahag?n. (2006) Nerve root degeneration and regeneration by intrathecal phenol in rats: a morphologic approach. Journal of the Peripheral Nervous System 11:4, pages 310-317.
Crossref
Crossref
Lauren C. Seeberger. 2006. Handbook of Dystonia. Handbook of Dystonia
371
380
.
Valerie Stevenson, Louise Jarrett & Alan Thompson. 2006. Spasticity Management. Spasticity Management
71
83
.
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
2800
2803
.
Ann H. Tilton. (2016) Injectable Neuromuscular Blockade in the Treatment of Spasticity and Movement Disorders. Journal of Child Neurology 18:1_suppl, pages S50-S66.
Crossref
Crossref
Jean-Michel Gracies & David M. Simpson. 2003.
651
695
.
Pam Magee. 2003.
258
261
.
Su-Ju Tsai, Henry L. Lew, Elaine Date & Liu-Ing Bih. (2002) Treatment of detrusor-sphincter dyssynergia by pudendal nerve block in patients with spinal cord injury. Archives of Physical Medicine and Rehabilitation 83:5, pages 714-717.
Crossref
Crossref
Ross D. Zafonte & Michael C. Munin. (2001) Phenol and Alcohol Blocks for the Treatment of Spasticity. Physical Medicine and Rehabilitation Clinics of North America 12:4, pages 817-832.
Crossref
Crossref
Elie Elovic. (2001) Principles of Pharmaceutical Management of Spastic Hypertonia. Physical Medicine and Rehabilitation Clinics of North America 12:4, pages 793-816.
Crossref
Crossref
Karen S.G. Chua & Keng-He Kong. (2000) Alcohol neurolysis of the sciatic nerve in the treatment of hemiplegic knee flexor spasticity: Clinical outcomes. Archives of Physical Medicine and Rehabilitation 81:10, pages 1432-1435.
Crossref
Crossref
Yeşim Kirazli. (1999) Letters to the Editor. American Journal of Physical Medicine & Rehabilitation 78:5, pages 500.
Crossref
Crossref
Arzu Yagiz On, Yesim Kirazli, Banu Kismali & Ramazan Aksit. (1999) MECHANISMS OF ACTION OF PHENOL BLOCK AND BOTULINUS TOXIN TYPE A IN RELIEVING SPASTICITY. American Journal of Physical Medicine & Rehabilitation 78:4, pages 344-349.
Crossref
Crossref
Yesim Kirazli, Arzu Yagiz On, Banu Kismali & Ramazan Aksit. (1998) COMPARISON OF PHENOL BLOCK AND BOTULINUS TOXIN TYPE A IN THE TREATMENT OF SPASTIC FOOT AFTER STROKE. American Journal of Physical Medicine & Rehabilitation 77:6, pages 510-515.
Crossref
Crossref
Patricia M. DaviesPatricia M. Davies. 1997. Een nieuw begin. Een nieuw begin
316
397
.
P Burbaud, L Wiart, J L Dubos, E Gaujard, X Debelleix, P A Joseph, J M Mazaux, B Bioulac, M Barat & A Lagueny. (1996) A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients.. Journal of Neurology, Neurosurgery & Psychiatry 61:3, pages 265-269.
Crossref
Crossref
Kathleen R. Bell. (1995) The Use of Neurolytic Blocks for the Management Of Spasticity. Physical Medicine and Rehabilitation Clinics of North America 6:4, pages 885-895.
Crossref
Crossref
Bradly S. Goodman, Brigitta B. Jann, J. David Haddox & Donald Denson. (1995) Subcutaneous bupivacaine for treatment of spasticity: A case report. Archives of Physical Medicine and Rehabilitation 76:2, pages 202-204.
Crossref
Crossref
Patricia M. DaviesPatricia M. Davies. 1995. Wieder Aufstehen. Wieder Aufstehen
460
467
.
DA Skeil & MP Barnes. (2016) The local treatment of spasticity. Clinical Rehabilitation 8:3, pages 240-246.
Crossref
Crossref
L. M. STERN. (2008) The management of cerebral palsy. Journal of Paediatrics and Child Health 26:4, pages 184-187.
Crossref
Crossref